Press Releases
Press Release
NanoString Partners with Multiple Leading Contract Research Organizations to Provide Standardized PanCancer IO 360 Data Analysis Reports
Program Extends Ability of CAP CLIA Labs to Develop a Tumor Inflammation Signature Assay to Support Translational Research by Biopharmaceutical Companies SEATTLE, May 30, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies,…
Press Release
NanoString to Present at the UBS Global Healthcare Conference
SEATTLE, May 15, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s…
Press Release
NanoString Technologies Releases Operating Results for First Quarter of 2019
SEATTLE, May 09, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the…
Press Release
NanoString to Release First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9, 2019
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will…
Press Release
NanoString and Leica Biosystems to Co-Market GeoMx Digital Spatial Profiling and Leica’s BOND RX Platforms for High Throughput Spatial Analysis
Combined Workflow Provides Complete Solution for Rapid, Automated, and Highly Multiplexed Profiling of Protein and RNA Biomarkers in FFPE Samples SEATTLE and NEWCASTLE UPON TYNE, UK, April 02, 2019 (GLOBE…
Press Release
NanoString and Abcam Enter Commercial Partnership to Provide Expanded Menu of Antibodies for GeoMx Digital Spatial Profiler
— Abcam to Develop Conjugated FFPE IHC Validated Antibodies Compatible with the GeoMx DSP — SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a…
Press Release
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
Integrated Workflow Combines NanoString’s GeoMx DSP High-Plex RNA Assays and Bio-Techne’s Highly Sensitive RNAscope Imaging Reagent Portfolio SEATTLE and MINNEAPOLIS, March 28, 2019 (GLOBE NEWSWIRE) -- Bio-Techne (NASDAQ:TECH), a global…
Press Release
NanoString Announces Commercial Launch of GeoMx Digital Spatial Profiler at the 2019 American Association of Cancer Research Conference
Complete Integrated Solution includes High-Throughput Instrument, Validated Protein & RNA Panels, and Integrated Data Analysis Software SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of…
Press Release
NanoString Highlights Record Number of nCounter and GeoMx Research Studies at 2019 American Association of Cancer Research (AACR) Conference
Approximately 70 Abstracts Showcase NanoString’s Platforms, Including 13 Studies Using the GeoMx Digital Spatial Profiler SEATTLE, March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life…
Press Release
NanoString Technologies Announces Closing of Public Offering of 5,175,000 Shares of Common Stock Including Exercise in Full of Option to Purchase Additional Shares
SEATTLE, March 25, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the closing of its…
Press Release
NanoString Technologies Announces Pricing of Public Offering of 4,500,000 Shares of Common Stock
SEATTLE, March 19, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of an…
Press Release
NanoString Technologies Announces Commencement of Public Offering of Common Stock
SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an underwritten public offering…